IP Library Granted Patent US 12,508,073
Granted Patent B2
US 12,508,073 · App. 17/406,008 · Granted Dec 30, 2025

Systems, devices, and methods for tissue layer removal

Inventors: Matthew Angle (Austin, TX); Mina-Elraheb Saad Hanna (Austin, TX); Kevin Boergens (Austin, TX); Yifan Kong (Austin, TX); Robert Edgington (Austin, TX); Kunal Sahasrabuddhe (Austin, TX); Devin Fell (Austin, TX); Harbaljit Sohal (Austin, TX); Matthew Stephen Hopper (Austin, TX); Aleksandar Tadic (Austin, TX)
Assignee: Paradromics, Inc.
A61B18/20A61B2018/00351A61B2018/00446A61B2018/00577A61B2018/00595A61B2018/00642A61B2018/00702A61B2018/00726A61B2018/00732A61B2018/00738A61B2018/00761A61B2018/20355A61B2018/20359A61B2018/20361A61B2218/005A61B2218/007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,508,073
App. No.
17/406,008
Granted
Dec 30, 2025
Kind
B2
Abstract

The present disclosure provides systems, devices, and methods for penetrating a biological membrane. The system may comprise a laser unit configured to generate one or more laser beams. The system may comprise a set of targeting optics configured to direct the one or more laser beams to a target region of the biological membrane. The system may comprise a raster scanner operatively coupled to the laser unit and the set of targeting optics. The system may comprise a non-transitory computer readable storage medium comprising a set of instructions. The set of instructions may be configured to control at least one of the laser unit, the set of targeting optics, or the raster scanner to photodisrupt the target region of the biological membrane to a target depth while minimizing damage to one or more blood vessels in proximity to the target region.

Claims (28)

1 . A method of penetrating a biological membrane in proximity to a subject's brain, comprising:

(a) identifying a target region of the biological membrane;

(b) photodisrupting the target region to a target depth to remove or ablate at least a portion of the biological membrane to expose underlying brain tissue, wherein the biological membrane is a pia mater, wherein the photodisrupting comprises using at least one light source and one or more optical elements, and wherein the at least one light source emits one or more pulses with a pulse energy density from about 1 μJ/cm 2 to about 100 J/cm 2 ; and

(c) inserting an implantable device comprising one or more high aspect ratio structures through the photodisrupted target region into a tissue below the biological membrane, wherein the tissue below the biological membrane comprises the underlying brain tissue, wherein the implantable device is configured to receive or transmit signals to the subject's brain.

2 . The method of claim 1 , further comprising removing one or more particles from (i) the target region or (ii) air surrounding the target region.

3 . The method of claim 2 , further comprising using a vacuum or a blower to remove the one or more particles from (i) the target region or (ii) the air surrounding the target region.

4 . The method of claim 2 , wherein the one or more particles are removed by flowing a gas across the target region.

5 . The method of claim 4 , wherein the gas humidifies one or more tissue regions in the target region to prevent the one or more tissue regions from drying out.

6 . The method of claim 4 , wherein the gas modulates an ablation characteristic or tissue response of one or more tissue regions in the target region.

7 . The method of claim 1 , wherein the one or more optical elements are configured to spatially block or redirect light from the at least one light source to (i) avoid ablating one or more blood vessels in proximity to the target region and (ii) minimize bleeding in or near the target region.

8 . The method of claim 1 , wherein at least a portion of the one or more optical elements are optically aligned with the at least one light source.

9 . The method of claim 1 , wherein the one or more optical elements comprise a mirror, a lens, a light cable, or one or more masks.

10 . The method of claim 1 , wherein the at least one light source is configured to generate a light pattern to avoid ablation of one or more blood vessels in proximity to the target region and to prevent bleeding in or near the target region.

11 . The method of claim 10 , wherein the at least one light source is configured to use image processing to generate the light pattern.

12 . The method of claim 11 , wherein the at least one light source is configured to interrupt laser pulses over the one or more blood vessels as ablation is being performed, based at least in part on one or more sensor readings or measurements.

13 . The method of claim 1 , further comprising using an image recognition module or one or more ranging sensors to actively or dynamically adjust a light pattern or a focus of the at least one light source to maintain uniform power on one or more tissue regions during ablation.

14 . The method of claim 1 , further comprising using a cauterization module to target one or more ablated blood vessels and to adjust a power or a focus of the at least one light source to cauterize the one or more ablated blood vessels post-ablation.

15 . The method of claim 1 , wherein in (b), the photodisrupting of the target region is performed at a predetermined intensity or for a predetermined time interval.

16 . The method of claim 1 , wherein the one or more high aspect ratio structures comprise a microwire, a microelectrode, or a probe.

17 . The method of claim 1 , wherein the at least one light source comprises light having a wavelength of at most 360 nm.

18 . The method of claim 1 , wherein the at least one light source has an average power of at least 0.1 milliwatts.

19 . The method of claim 1 , wherein the at least one light source comprises a pulsed laser, wherein the pulsed laser is configured to generate the one or more pulses, the one or more pulses having (i) a duration of 1 picosecond to 10 microseconds or (ii) a predetermined pulse repetition frequency between 1 hertz (Hz) and 100 megahertz (MHz).

20 . The method of claim 1 , wherein the implantable device is a brain machine interface (BMI) device.

21 . The method of claim 1 , wherein the implantable device is configured to record neural signals.

22 . A method of penetrating a biological membrane in proximity to a subject's brain, comprising:

(a) identifying a target region of the biological membrane;

(b) photodisrupting the target region to a target depth to remove at least a portion of the biological membrane to expose underlying brain tissue, wherein the biological membrane is a pia mater, wherein the photodisrupting comprises using at least one light source and one or more optical elements, and wherein the at least one light source emits one or more pulses with a pulse energy density from about 1 μJ/cm 2 to about 100 J/cm 2 ; and

(c) inserting one or more high aspect ratio structures through the photodisrupted target region into a tissue below the biological membrane, wherein the tissue below the biological membrane comprises the underlying brain tissue.

Assignments (2)
CONFIRMATORY LICENSE Recorded Apr 30, 2024
From: PARADROMICS, INC.
To: THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY
Reel/Frame 067266/0502 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2022
From: ANGLE, MATTHEW; HANNA, MINA-ELRAHEB SAAD; BOERGENS, KEVIN; KONG, YIFAN; EDGINGTON, ROBERT; SAHASRABUDDHE, KUNAL; FELL, DEVIN; SOHAL, HARBALJIT; HOPPER, MATTHEW STEPHEN; TADIC, ALEKSANDAR
To: PARADROMICS, INC.
Reel/Frame 058808/0906 →
Continuity (3)
Continuation PCTUS2020020422 · Feb 28, 2020
Provisional Application 62812913 · Mar 1, 2019
Related Publication 20220110681A1 · Apr 14, 2022
References Cited (14)
US 6258082B1 · Lin · 2001 [cited by examiner]
US 8353899B1 · Wells · 2013 [cited by examiner]
US 9277964B1 · Hasling · 2016 [cited by examiner]
US 20060173263A1 · He · 2006 [cited by examiner]
US 20110040358A1 · Bean et al. · 2011 [cited by applicant]
US 20110208054A1 · Stewart · 2011 [cited by examiner]
US 20120000893A1 · Broude et al. · 2012 [cited by applicant]
US 20130035676A1 · Mitchell et al. · 2013 [cited by applicant]
US 20160022146A1 · Piron · 2016 [cited by examiner]
US 20170014271A1 · Degani et al. · 2017 [cited by applicant]
US 20170290521A1 · Angle et al. · 2017 [cited by applicant]
WO WO2020180696A1 · 2020 [cited by applicant]
PCT/US2020/020422 International Search Report and Written Opinion dated May 11, 2020. [cited by applicant]
Seeds. Diagnostic mid trimester amniocentesis: How safe? American Journal of Obstetrics and Gynecology (2004) 191, 608-16. Presented at the Sixty-Sixth Annual Meeting of the South Atlantic Association of Obstetricians a… [cited by applicant]